Literature DB >> 15784572

Immunoglobulin G isotype responses to erythrocyte surface-expressed variant antigens of Plasmodium falciparum predict protection from malaria in African children.

Clarisse L R P Yone1, Peter G Kremsner, Adrian J F Luty.   

Abstract

We assessed immunoglobulin G (IgG) isotype responses to variant surface antigens (VSA) expressed on parasite-infected erythrocytes of a panel of heterologous isolates during and after acute episodes in groups of Gabonese children presenting with either mild or severe Plasmodium falciparum malaria. In the acute and convalescent phases IgG3 and IgG1 anti-VSA antibodies, respectively, predominated. In the absence of infection, the levels of both cytophilic isotypes waned, while those of IgG4 increased, particularly in those admitted with severe malaria. Prospective analyses showed significantly longer delays between malaria attacks associated both (i) with increasing IgG1 responses with specificity for VSA of isolates from children with mild malaria and (ii) with increasing IgG4 responses with specificity for VSA of isolates from children with severe malaria. These findings imply that the predictive value of prospectively measured cross-reactive VSA-specific IgG antibodies with respect to protection against malaria in African children depends both on their isotype and on their fine specificity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784572      PMCID: PMC1087392          DOI: 10.1128/IAI.73.4.2281-2287.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Antibodies to Plasmodium falciparum rifin proteins are associated with rapid parasite clearance and asymptomatic infections.

Authors:  Mohamed S Abdel-Latif; Klaus Dietz; Saadou Issifou; Peter G Kremsner; Mo-Quen Klinkert
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

2.  Immunoglobulin G isotype responses to variant surface antigens of Plasmodium falciparum in healthy Gabonese adults and children during and after successive malaria attacks.

Authors:  Gerardo Cabrera; Clarisse Yone; Anne E Tebo; Jan van Aaken; Bertrand Lell; Peter G Kremsner; Adrian J F Luty
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  Temporal variations in immune responses to conserved regions of Plasmodium falciparum merozoite surface proteins related to the severity of a prior malaria episode in Gabonese children.

Authors:  Carsten Köhler; Anne E Tebo; Beatrice Dubois; Philippe Deloron; Peter G Kremsner; Adrian J F Luty
Journal:  Trans R Soc Trop Med Hyg       Date:  2003 Jul-Aug       Impact factor: 2.184

4.  Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection.

Authors:  K Marsh; L Otoo; R J Hayes; D C Carson; B M Greenwood
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 May-Jun       Impact factor: 2.184

5.  Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens.

Authors:  Samson M Kinyanjui; Peter Bull; Christopher I Newbold; Kevin Marsh
Journal:  J Infect Dis       Date:  2003-02-07       Impact factor: 5.226

6.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

7.  Low antibody responses to variant surface antigens of Plasmodium falciparum are associated with severe malaria and increased susceptibility to malaria attacks in Gabonese children.

Authors:  Anne E Tebo; Peter G Kremsner; Karen P Piper; Adrian J F Luty
Journal:  Am J Trop Med Hyg       Date:  2002-12       Impact factor: 2.345

8.  Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria.

Authors:  Ali Salanti; Trine Staalsoe; Thomas Lavstsen; Anja T R Jensen; M P Kordai Sowa; David E Arnot; Lars Hviid; Thor G Theander
Journal:  Mol Microbiol       Date:  2003-07       Impact factor: 3.501

9.  Fcgamma receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro.

Authors:  A E Tebo; P G Kremsner; A J F Luty
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

10.  Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes.

Authors:  Anja T R Jensen; Pamela Magistrado; Sarah Sharp; Louise Joergensen; Thomas Lavstsen; Antonella Chiucchiuini; Ali Salanti; Lasse S Vestergaard; John P Lusingu; Rob Hermsen; Robert Sauerwein; Jesper Christensen; Morten A Nielsen; Lars Hviid; Colin Sutherland; Trine Staalsoe; Thor G Theander
Journal:  J Exp Med       Date:  2004-05-03       Impact factor: 14.307

View more
  12 in total

1.  Placental malaria induces variant-specific antibodies of the cytophilic subtypes immunoglobulin G1 (IgG1) and IgG3 that correlate with adhesion inhibitory activity.

Authors:  Salenna R Elliott; Amy K Brennan; James G Beeson; Eyob Tadesse; Malcolm E Molyneux; Graham V Brown; Stephen J Rogerson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  IgG isotypic antibodies to crude Plasmodium falciparum blood-stage antigen associated with placental malaria infection in parturient Cameroonian women.

Authors:  Judith K Anchang-Kimbi; Eric Akum Achidi; Blaise Nkegoum; Joseph-Marie N Mendimi; Eva Sverremark-Ekström; Marita Troye-Blomberg
Journal:  Afr Health Sci       Date:  2016-12       Impact factor: 0.927

3.  The humoral response to Plasmodium falciparum VarO rosetting variant and its association with protection against malaria in Beninese children.

Authors:  Inès Vigan-Womas; Adjimon Lokossou; Micheline Guillotte; Alexandre Juillerat; Graham Bentley; André Garcia; Odile Mercereau-Puijalon; Florence Migot-Nabias
Journal:  Malar J       Date:  2010-10-05       Impact factor: 2.979

Review 4.  Acquired immunity to malaria.

Authors:  Denise L Doolan; Carlota Dobaño; J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

5.  Decreased growth rate of P. falciparum blood stage parasitemia with age in a holoendemic population.

Authors:  Mykola Pinkevych; Janka Petravic; Kiprotich Chelimo; John Vulule; James W Kazura; Ann M Moormann; Miles P Davenport
Journal:  J Infect Dis       Date:  2013-11-21       Impact factor: 5.226

6.  The dynamics of naturally acquired immunity to Plasmodium falciparum infection.

Authors:  Mykola Pinkevych; Janka Petravic; Kiprotich Chelimo; James W Kazura; Ann M Moormann; Miles P Davenport
Journal:  PLoS Comput Biol       Date:  2012-10-18       Impact factor: 4.475

7.  Evaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon.

Authors:  Lilian Rose Pratt-Riccio; Selma Sallenave-Sales; Joseli de Oliveira-Ferreira; Bruno T da Silva; Monick Lindenmeyer Guimarães; Fátima Santos; Thatiane S de Simone; Mariza G Morgado; Salvatore G de Simone; Maria de Fátima Ferreira-Da-Cruz; Cláudio T Daniel-Ribeiro; Mariano G Zalis; Daniel Camus; Dalma M Banic
Journal:  Malar J       Date:  2008-07-30       Impact factor: 2.979

8.  Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults.

Authors:  Arlene E Dent; Elke S Bergmann-Leitner; Danny W Wilson; Daniel J Tisch; Rhonda Kimmel; John Vulule; Peter Odada Sumba; James G Beeson; Evelina Angov; Ann M Moormann; James W Kazura
Journal:  PLoS One       Date:  2008-10-29       Impact factor: 3.240

9.  Differential evolution of anti-VAR2CSA- IgG3 in primigravidae and multigravidae pregnant women infected by Plasmodium falciparum.

Authors:  Juliette Guitard; Gilles Cottrell; Nellie Moulopo Magnouha; Ali Salanti; Tengfei Li; Sokhna Sow; Philippe Deloron; Nicaise Tuikue Ndam
Journal:  Malar J       Date:  2008-01-11       Impact factor: 2.979

Review 10.  Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates.

Authors:  Jo-Anne Chan; Freya J I Fowkes; James G Beeson
Journal:  Cell Mol Life Sci       Date:  2014-04-02       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.